June 06, 2024
A California federal judge won't free Abbott Laboratories from a proposed class action over its Glucerna shakes, saying the complaint plausibly alleges that the labeling would mislead consumers about the health aspects of the drinks.
November 07, 2023
Abbott Laboratories wants a California federal court to throw out a potential class action alleging the company misled consumers by billing its Glucerna shakes as being scientifically designed for people with diabetes when the ingredients are actually harmful to them.
August 25, 2023
A California man has hit Abbott Laboratories with a suit alleging that the company misleads consumers by claiming that its Glucerna shakes are formulated to help with diabetes when they actually contain ingredients that can be harmful to diabetics.